Search - Centre François Baclesse Access content directly

Filter your results

52 Results
Deposit type : Notice

Radiotherapy of T4M0 prostate cancer : A multicentric retrospective analysis

F. Goupy , E. Meyer , P. Pommier , N. Magne , P. Sargos et al.
Radiotherapy & Oncology, 2020, 152, pp.S59-S59
Journal articles hal-03284472v1

Delineation guidelines for the lymphatic target volumes in ‘prone crawl’ radiotherapy treatment position for breast cancer patients

Guillaume Janoray , Yoann Pointreau , Marc Alfonsi , Christian Sire , Lionel Geoffrois et al.
Scientific Reports, 2021, 11 (1), pp.22529. ⟨10.1038/s41598-021-01841-y⟩
Journal articles hal-03657494v1

[2021 update of the GEFPICS’ recommendations for HER2 status assessment in invasive breast cancer in France]

Camille Franchet , Lounes Djerroudi , Aurélie Maran-Gonzalez , Olivia Abramovici , Martine Antoine et al.
Annales de Pathologie, 2021, ⟨10.1016/j.annpat.2021.07.014⟩
Journal articles hal-03333764v1

Impact of body mass index on overall survival in patients with metastatic breast cancer

Khalil Saleh , Matthieu Carton , Véronique Dieras , Pierre-Etienne Heudel , Etienne Brain et al.
Breast, 2021, 55, pp.16-24. ⟨10.1016/j.breast.2020.11.014⟩
Journal articles hal-03345238v1

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

Nicolas Penel , Olivier Mir , Jennifer Wallet , Isabelle Ray-Coquard , Axel Le Cesne et al.
European Journal of Cancer, 2020, 126, pp.45-55. ⟨10.1016/j.ejca.2019.12.001⟩
Journal articles hal-03623680v1

Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial

C. Falandry , F. Rousseau , M. A. Mouret-Reynier , F. Tinquaut , D. Lorusso et al.
JAMA oncology, 2021, 7 (6), pp.853-861. ⟨10.1001/jamaoncol.2021.0696⟩
Journal articles inserm-03344388v1

Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial

Stéphane Culine , Valentin Harter , Gwenaelle Gravis , Aude Fléchon , Christine Chevreau et al.
Clinical Genitourinary Cancer, 2021, 19 (6), pp.554-562. ⟨10.1016/j.clgc.2021.08.005⟩
Journal articles hal-03625944v1

Tachycardies ventriculaires réfractaires : quelle place pour la radiothérapie et comment ?

R Jumeau , É Pruvot , J Thariat , I Latorzeff , P-U Milliez et al.
Cancer/Radiothérapie, 2020, 24 (6-7), pp.534-546. ⟨10.1016/j.canrad.2020.06.005⟩
Journal articles hal-02958971v1

First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50%

Renaud Descourt , Christos Chouaid , Maurice Pérol , Benjamin Besse , Laurent Greillier et al.
Future Oncology, 2021, 17 (23), pp.3007-3016. ⟨10.2217/fon-2020-1202⟩
Journal articles hal-03526346v1

Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program

Laurence Albiges , Aude Fléchon , Christine Chevreau , Delphine Topart , Gwenaëlle Gravis et al.
European Journal of Cancer, 2021, 142, pp.102-111. ⟨10.1016/j.ejca.2020.09.030⟩
Journal articles hal-03623382v1

Trends in incidence of invasive vaginal cancer in France from 1990 to 2018 and survival of recently diagnosed women – A population-based study

Brigitte Trétarre , Emmanuelle Dantony , Gaëlle Coureau , Gautier Defossez , Anne-Valérie Guizard et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2023, 283, pp.125-129. ⟨10.1016/j.ejogrb.2023.02.003⟩
Journal articles hal-04012030v1

Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective study

Gilles Houvenaeghel , Alexandre De Nonneville , Monique Cohen , Jean-Marc Classe , Fabien Reyal et al.
European Journal of Cancer, 2022, 176, pp.58-69. ⟨10.1016/j.ejca.2022.08.027⟩
Journal articles hal-04084967v1

Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study

Diane Goere , Olivier Glehen , Francois Quenet , Jean-Marc Guilloit , Jean-Marc Bereder et al.
Lancet Oncology, 2020, 21 (9), pp.1147-1154. ⟨10.1016/S1470-2045(20)30322-3⟩
Journal articles hal-03597470v1

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients

Alexis Maillard , Rabah Redjoul , Marion Klemencie , Hélène Labussière Wallet , Amandine Le Bourgeois et al.
Blood, 2022, 139 (1), pp.134-137. ⟨10.1182/blood.2021014232⟩
Journal articles hal-03602166v1

Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer

Thomas Bachelot , Paul Cottu , Sylvie Chabaud , Florence Dalenc , Djelila Allouache et al.
Journal of Clinical Oncology, 2022, 40 (32), pp.3699-3708. ⟨10.1200/JCO.21.02179⟩
Journal articles hal-03857382v1

Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study

Stéphane Culine , Aude Fléchon , Gwenaelle Gravis , Guilhem Roubaud , Yohann Loriot et al.
Clinical Genitourinary Cancer, 2021, 19 (4), pp.e216-e222. ⟨10.1016/j.clgc.2021.02.005⟩
Journal articles hal-03631553v1

[COVID-19 and People Followed for Breast Cancer: French Guidelines for Clinical Practice of Nice-St Paul De Vence, in Collaboration With the Collège Nationale Des Gynécologues Et Obstétriciens Français (CNGOF), the Société d'Imagerie De La Femme (SIFEM), the Société Française De Chirurgie Oncologique (SFCO), the Société Française De Sénologie Et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)]

Joseph Gligorov , Thomas Bachelot , Jean-Yves Pierga , Eric-Charles Antoine , Corinne Balleyguier et al.
Bulletin du Cancer, 2020, 107 (5), pp.528-537. ⟨10.1016/j.bulcan.2020.03.008⟩
Journal articles hal-02869600v1

Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis

Elvire Pons-Tostivint , Youlia Kirova , Amélie Lusque , Mario Campone , Julien Geffrelot et al.
Radiotherapy & Oncology, 2020, 145, pp.109-116. ⟨10.1016/j.radonc.2019.12.019⟩
Journal articles hal-02888440v1

Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies

Dimitri Carene , Alicia Tran-Dien , Jérôme Lemonnier , Florence Dalenc , Christelle Levy et al.
Breast Cancer Research and Treatment, 2020, 179 (2), pp.387-401. ⟨10.1007/s10549-019-05462-y⟩
Journal articles hal-03769556v1

Parental disclosure of positive BRCA1/2 mutation status to children 10 years after genetic testing

Jaïs Troian , Thémis Apostolidis , Rajae Touzani , Emmanuelle Mouret-Fourme , Dominique Stoppa-Lyonnet et al.
Psychology, Health and Medicine, 2020, pp.1-11. ⟨10.1080/13548506.2019.1659981⟩
Journal articles hal-02541592v1

Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy

Antonio Di Meglio , Julie Havas , Arnauld S. Gbenou , Elise Martin , Mayssam El-Mouhebb et al.
Journal of Clinical Oncology, 2022, 40 (27), pp.3190--3204. ⟨10.1200/JCO.21.00277⟩
Journal articles hal-03855946v1

Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care

Antonio Di Meglio , Julie Havas , Davide Soldato , Daniele Presti , Elise Martin et al.
Journal of Clinical Oncology, 2022, 40 (10), pp.1111--1123. ⟨10.1200/JCO.21.01252⟩
Journal articles hal-03855945v1

Postoperative radiotherapy after flap reconstructive surgery in patients with head and neck cancer: A retrospective monocentric study with flap delineation to assess toxicity and relapse

G. Michaël , J. Le guevelou , N. Jacksic , J. Lequesne , V. Bastit et al.
Cancer/Radiothérapie, 2020, 24 (8), pp.851-859. ⟨10.1016/j.canrad.2020.06.024⟩
Journal articles hal-02989401v1

SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer

Emeric Boisteau , Eric François , Thomas Aparicio , Karine Le Malicot , Rabia Boulahssass et al.
Digestive and Liver Disease, 2022, 54 (6), pp.747-754. ⟨10.1016/j.dld.2022.03.001⟩
Journal articles hal-03632563v1

PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer

Alexandre Bertucci , F. Bertucci , Christophe Zemmour , Florence Lerebours , Jean-Yves Pierga et al.
Frontiers in Oncology, 2020, 10, ⟨10.3389/fonc.2020.575978⟩
Journal articles hal-03623650v1

Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study

Renaud Sabatier , Cécile Vicier , Séverine Garnier , Arnaud Guille , Nadine Carbuccia et al.
Molecular Oncology, 2022, ⟨10.1002/1878-0261.13188⟩
Journal articles hal-03583253v1

A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery

P. Pautier , A. Floquet , C. Chevreau , N. Penel , C. Guillemet et al.
ESMO Open, 2021, 6 (4), pp.100209. ⟨10.1016/j.esmoop.2021.100209⟩
Journal articles hal-03623631v1

Interactions of Radiation Therapy with Common and Innovative Systemic Treatments: Antidiabetic Treatments, Antihypertensives, Lipid-Lowering Medications, Immunosuppressive Medications and Other Radiosensitizing Methods.

Y. Zhou , A. Larnaudie , Y. Ghannam , L. Ollivier , Y. Gounane et al.
Cancer/Radiothérapie, 2022, pp.S1278-3218(22)00135-4. ⟨10.1016/j.canrad.2022.06.030⟩
Journal articles hal-03767981v1

Risk perceptions and health care use in the era of the COVID-19 pandemic in adults treated for childhood cancer

Asmaa Janah , Charlotte Demoor-Goldschmidt , Florent de Vathaire , Nicolas Bougas , Jacqueline Clavel et al.
Supportive Care in Cancer, 2022, 30 (7), pp.6263-6271. ⟨10.1007/s00520-022-07035-0⟩
Journal articles hal-04032845v1

Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus “at progression” cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis

Isabelle Monnet , Alain Vergnenègre , Gilles Robinet , Henri Berard , Regine Lamy et al.
Therapeutic Advances in Medical Oncology, 2021, 13, pp.175883592110069. ⟨10.1177/17588359211006983⟩
Journal articles hal-03526393v1